Your browser doesn't support javascript.
loading
Longitudinal data on humoral response and neutralizing antibodies against SARS-CoV-2 Omicron BA.1 and subvariants BA.4/5 and BQ.1.1 after COVID-19 vaccination in cancer patients.
Overheu, Oliver; Lendowski, Simon; Quast, Daniel R; Kühn, Daniel; Vidal Blanco, Elena; Kraeft, Anna-Lena; Steinmann, Eike; Kourti, Eleni; Lugnier, Celine; Steinmann, Joerg; Reinacher-Schick, Anke; Pfaender, Stephanie.
Afiliação
  • Overheu O; Department of Hematology and Oncology with Palliative Care, St. Josef Hospital, Ruhr University, Bochum, Germany. o.overheu@klinikum-bochum.de.
  • Lendowski S; Department of Hematology and Oncology with Palliative Care, St. Josef Hospital, Ruhr University, Bochum, Germany.
  • Quast DR; Department of Internal Medicine, St. Josef Hospital, Ruhr University, Bochum, Germany.
  • Kühn D; Department of Molecular and Medical Virology, Ruhr University, Bochum, Germany.
  • Vidal Blanco E; Department of Molecular and Medical Virology, Ruhr University, Bochum, Germany.
  • Kraeft AL; Department of Hematology and Oncology with Palliative Care, St. Josef Hospital, Ruhr University, Bochum, Germany.
  • Steinmann E; Department of Molecular and Medical Virology, Ruhr University, Bochum, Germany.
  • Kourti E; Department of Hematology and Oncology with Palliative Care, St. Josef Hospital, Ruhr University, Bochum, Germany.
  • Lugnier C; Department of Hematology and Oncology with Palliative Care, St. Josef Hospital, Ruhr University, Bochum, Germany.
  • Steinmann J; Institute of Clinical Hygiene, Medical Microbiology and Infectiology, Klinikum Nürnberg, Paracelsus Medical University, Nuremberg, Germany.
  • Reinacher-Schick A; Department of Hematology and Oncology with Palliative Care, St. Josef Hospital, Ruhr University, Bochum, Germany.
  • Pfaender S; Department of Molecular and Medical Virology, Ruhr University, Bochum, Germany.
J Cancer Res Clin Oncol ; 149(12): 10633-10644, 2023 Sep.
Article em En | MEDLINE | ID: mdl-37300723

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 / Neoplasias Tipo de estudo: Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 / Neoplasias Tipo de estudo: Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article